Skip to main content

Table 2 Rescue medication list

From: Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study

 

Cross-over study arm

Total

 

Frovatriptan

Rizatriptan

Active compounds

n (%)

n (%)

n (%)

Ibuprofen

25(23.2)

23(24)

48(23.5)

Nimesulide

21(19.4)

15(15.6)

36(17.7)

Paracetamol/codeine

13(12)

8(8.3)

21(10.3)

Ketoprofen

7(6.48)

9(9.4)

16(7.8)

Diclofenac

4(3.7)

7(7.3)

11(5.4)

Indomethacin

8(7.4)

3(3.1)

11(5.4)

Naproxen

7(6.5)

3(3.1)

10(4.9)

Ketorolac

5(4.6)

4(4.2)

9(4.4)

Paracetamol

5(4.6)

2(2.1)

7(3.4)

Frovatriptan*

1(0.9)

6(6.3)

7(2.5)

Piroxicam

3(2.8)

2(2.1)

5(2)

Metamizol

1(0.9)

3(3.1)

4(2)

Metoclopramide

1(0.9)

3(3.1)

4(1.5)

Acetylsalicylic acid

3(2.8)

0

3(1)

Eletriptan*

1(0.9)

2(2.1)

3(0.5)

Indomethacin/caffeine/prochlorperazine

0

2(2.1)

2(1)

Almotriptan*

1(0.9)

1(1)

2(3.4)

Sumatriptan*

0

2(2.1)

2(1)

Propiphenazon/butalbital/caffeine

1(0.9)

0

1(0.5)

Rizatriptan*

0

1(1)

1(1.5)

Betamethasone

1(0.9)

0

1(0.5)

Total

108

96

204

  1. *Patients who used triptans as rescue medications were excluded from the per protocol analysis and were included in intention-to-treat analysis.